Healthcare: 2 Hot Biotech Stocks On Our Radar

Industry Focus - Podcast tekijän mukaan The Motley Fool

Kategoriat:

How Regenxbio is capitalizing on the emerging gene therapy trend and why Neurocrine Biosciences is on the cusp of making the jump to profitability. Also, how Amarin may revolutionize how doctors treat heart disease. Stocks: RGNX, NVS, NBIX, ABBV, AMRN.

Visit the podcast's native language site